[{"address1": "1017 Ranch Road 620 South", "address2": "Suite 107", "city": "Lakeway", "state": "TX", "zip": "78734", "country": "United States", "phone": "(512) 598-0931", "website": "https://www.anebulo.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joseph F. Lawler M.D., Ph.D.", "age": 51, "title": "Founder & Chairman", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 11000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kenneth C. Cundy Ph.D.", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 425150, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard Anthony Cunningham", "age": 52, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel V. George", "age": 53, "title": "Principal Accounting Officer, Acting CFO & Secretary", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott L. Anderson", "title": "Head of Investor Relations & Public Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.88, "open": 1.8, "dayLow": 1.7572, "dayHigh": 1.83, "regularMarketPreviousClose": 1.88, "regularMarketOpen": 1.8, "regularMarketDayLow": 1.7572, "regularMarketDayHigh": 1.83, "beta": -1.02, "forwardPE": -3.272727, "volume": 5182, "regularMarketVolume": 5182, "averageVolume": 5846, "averageVolume10days": 3990, "averageDailyVolume10Day": 3990, "marketCap": 46679760, "fiftyTwoWeekLow": 1.62, "fiftyTwoWeekHigh": 4.05, "fiftyDayAverage": 2.2055, "twoHundredDayAverage": 2.41743, "currency": "USD", "enterpriseValue": 43607308, "floatShares": 3912285, "sharesOutstanding": 25933200, "sharesShort": 12466, "sharesShortPriorMonth": 14346, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0005, "heldPercentInsiders": 0.65378, "heldPercentInstitutions": 0.28179002, "shortRatio": 5.73, "shortPercentOfFloat": 0.003, "impliedSharesOutstanding": 25933200, "bookValue": 0.192, "priceToBook": 9.375, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -9347314, "trailingEps": -0.37, "forwardEps": -0.55, "52WeekChange": -0.3333333, "SandP52WeekChange": 0.24014747, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ANEB", "underlyingSymbol": "ANEB", "shortName": "Anebulo Pharmaceuticals, Inc.", "longName": "Anebulo Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1620394200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fc68cd91-6097-3786-8f7e-3d915060bcb8", "messageBoardId": "finmb_673614867", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.8, "recommendationMean": 1.7, "recommendationKey": "buy", "totalCash": 5147139, "totalCashPerShare": 0.198, "quickRatio": 5.095, "currentRatio": 5.316, "returnOnAssets": -0.57903, "returnOnEquity": -1.04283, "freeCashflow": -5511286, "operatingCashflow": -8887156, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]